Filing metadata

Accession number
0000905148-24-001566
Form type
Form 4
Filer
Acrivon Therapeutics, Inc.
CIK
CIK 1781174
Filed
May 21, 2024
Reporting period
May 17, 2024
Description
Insider transaction

Explore SEC Filings Hub